Fisher, Bonadonna Studies Still Fuel DeVita’s Optimism; Carbon Lists Six Basic Research Needs
In Brief: NCI-Litton Negations On Frederick continue; Staffs Not Worried About Possible GAO Probe
NCI to Undergo More GAO Probes
Proflavine Bioassay Ineffective, NCI Says
New Saccharin Studies Convince FDA It A Carcinogen
Upton Briefed On Problems; To Start July 25
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded” - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel









